Table of contents

Papers

• A novel quality of life instrument for deep brain stimulation in movement disorders (21 July, 2003)

  A Kuehler, G Henrich, U Schroeder, B Conrad, P Herschbach, A Ceballos-Baumann
• Identification of target areas for deep brain stimulation in human basal ganglia substructures based on median nerve sensory evoked potential criteria (21 July, 2003)

  F Klostermann, J Vesper, G Curio
• Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: evaluation of active electrode contacts (21 July, 2003)

  W Hamel, U Fietzek, A Morsnowski, B Schrader, J Herzog, D Weinert, G Pfister, D Müller, J Volkmann, G Deuschl, H M Mehdorn
• Long term neuropsychological outcome after head injury: relation to APOE genotype (21 July, 2003)

  K Millar, J A R Nicoll, S Thornhill, G D Murray, G M Teasdale
• Cerebral vasomotor reactivity testing in head injury: the link between pressure and flow (21 July, 2003)

  E W Lang, J Lagopoulos, J Griffith, K Yip, A Yam, Y Mudaliar, H M Mehdorn, N W C Dorsch
• Social deprivation and adult head injury: a national study (21 July, 2003)

  L Dunn, J Henry, D Beard
• Counterfactual cognitive deficit in persons with Parkinson’s disease (21 July, 2003)

  P McNamara, R Durso, A Brown, A Lynch
• Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson’s disease: a randomised, placebo controlled, double blind, six month study (21 July, 2003)

  D J Brooks, H Sagar, The Uk-Irish Entacapone Study Group
• Post-transplantation HTLV-1 myelopathy in three recipients from a single donor (21 July, 2003)

  J J Zarranz Imirizaldu, J C Gomez Esteban, I Rouco Axpe, T Perez Concha, F Velasco Juanes, I Allue Susaeta, J M Corral Carranceja
• Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls (21 July, 2003)

  M T T Silva, P Mattos, A Alfano, A Q-C Araújo
• Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon β-1a (Rebif) treatment trial (21 July, 2003)

  X Lin, C R Tench, B Turner, L D Blumhardt, C S Constantinescu
• The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists (21 July, 2003)

  M Holtkamp, F Masuhr, L Harms, K M Einhäupl, H Meierkord, K Buchheim
• Antithrombotic drugs in secondary stroke prevention among a community dwelling older population (21 July, 2003)

  F Landi, M Cesari, G Onder, V Zamboni, F Lattanzio, A Russo, C Barillaro, R Bernabei
• Evidence of underdiagnosis of myasthenia gravis in older people (21 July, 2003)

  A Vincent, L Clover, C Buckley, J Grimley Evans, P M Rothwell
• Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene (21 July, 2003)

  D Bönsch, A Schwindt, P Navratil, D Palm, C Neumann, S Klimpe, J Schickel, J Hazan, C Weiller, T Deufel, J Liepert
• Hemisensory syndrome is associated with a low diagnostic yield and a nearly uniform benign prognosis (21 July, 2003)

  C Toth
• Predictors of successful self control during brain-computer communication (21 July, 2003)

  N Neumann, N Birbaumer